CareDx CFO Departs; New Directors Appointed

Ticker: CDNA · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1217234

Sentiment: neutral

Topics: executive-departure, board-changes, appointment

Related Tickers: CDNA

TL;DR

CFO out, new docs on board. Big changes at CareDx.

AI Summary

CareDx, Inc. announced on January 6, 2025, the departure of its Chief Financial Officer, Michael McCarty, effective January 10, 2025. The company also announced the appointment of Dr. Alex Wong as interim Chief Medical Officer and the election of two new directors, Dr. Michael J. Hostetter and Ms. Jennifer L. McNeely, to its Board of Directors, effective January 6, 2025.

Why It Matters

The departure of a CFO can signal financial strategy shifts or internal challenges, while new board members may bring fresh perspectives or influence future company direction.

Risk Assessment

Risk Level: medium — Changes in key executive positions and board composition can introduce uncertainty regarding future strategy and financial performance.

Key Players & Entities

FAQ

Who has been appointed as the interim Chief Medical Officer?

Dr. Alex Wong has been appointed as the interim Chief Medical Officer.

When is Michael McCarty's departure as CFO effective?

Michael McCarty's departure as CFO is effective January 10, 2025.

Who are the newly elected directors to CareDx's Board?

Dr. Michael J. Hostetter and Ms. Jennifer L. McNeely have been elected as new directors.

What is the effective date for the new directors' election?

The election of the new directors is effective January 6, 2025.

What is the company's principal executive address?

The company's principal executive address is 8000 Marina Boulevard, 4th Floor, Brisbane, California 94005.

Filing Stats: 634 words · 3 min read · ~2 pages · Grade level 12.9 · Accepted 2025-01-08 16:30:15

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 CareDx, Inc. Outside Director Compensation Policy, as amended and restated January 6, 2025. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 8, 2025 CAREDX, INC. By: /s/ John Hanna John Hanna Chief Executive Officer - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing